Physician profile
Daniel C Clark
NPI 1396733093
$30,654.13
in general payments reported to CMS, 2019-2025
26 companies · $215 in 2025
The $215 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $230 · 2021: $5,591 · 2022: $4,551 · 2023: $5,388 · 2024: $395 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,000 · Food and Beverage: $972 · Entertainment: $25.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,000.00 |
| Food and Beverage | $972.20 |
| Entertainment | $25.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $29,294.77 | 2019-2024 | Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $293.02 | 2019-2024 | Gore Synecor Biomaterial |
| Myriad Genetic Laboratories, INC. | $198.57 | 2021-2024 | Myrisk, Bracanalysis Cdx |
| Ethicon US, LLC | $136.56 | 2019-2025 | Enseal X1, Echelon; Endopath, Stratafix |
| Smith+Nephew, INC. | $118.65 | 2019-2025 | Stravix, Grafix Pl |
| Cumberland Pharmaceuticals, INC. | $99.97 | 2019-2023 | Caldolor |
| Janssen Pharmaceuticals, INC | $71.47 | 2019-2024 | Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $61.35 | 2019-2020 | |
| Hologic Sales and Service, LLC | $38.22 | 2025 | Magtrace, Sentimag |
| Stryker Corporation | $32.99 | 2022-2024 | 1788, Switchpoint Infinity, Isuite |
| Bard Peripheral Vascular, INC. | $30.91 | 2024 | Powerport M.R.I. Implantable Port |
| Kub Technologies INC. | $25.72 | 2023 | Mozart |
| Ferring Pharmaceuticals INC. | $25.20 | 2019 | |
| Baudax Bio INC. | $24.89 | 2020 | |
| Lemaitre Vascular, INC. | $23.26 | 2025 | Xenosure Biologic Patch |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $22.93 | 2024 | Endurant Iis |
| Innocoll Pharmaceuticals Limited | $18.52 | 2022 | |
| Silk Road Medical, INC. | $17.91 | 2022 | |
| Karl Storz Endoscopy-America | $17.02 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $16.43 | 2025 | Exparel |
| Inari Medical, INC. | $16.00 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Shire North American Group INC | $15.62 | 2019 | |
| Lilly USA, LLC | $14.82 | 2024 | Zepbound |
| Csl Behring | $14.82 | 2019 | |
| Abbvie INC. | $12.50 | 2022 | |
| Acelrx Pharmaceuticals, INC. | $12.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.